Is Glenmark Pharmaceuticals stock a buy?

Yes, Glenmark Pharmaceuticals pays dividends. Last time was Sunday 27th of October 2024 where the investors holding the stock on Monday 16th of September 2024 were paid INR2.5 per share. Over the last 23 times between 2002 and 2024, Glenmark Pharmaceuticals has paid INR46.4 with an average of INR2.02 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Glenmark Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR384.60, you would have made a profit of INR1 318.10 per share or 342.72%

Yes, the average daily trading liquidity for Glenmark Pharmaceuticals is INR949 604 thousand. You should therefore be able to get in and out of your positions relatively fast.

Glenmark Pharmaceuticals has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.72, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Glenmark Pharmaceuticals to be low [0.3 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.